Epidemiology & Genomics Research Program
Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Funding Opportunities
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
.
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
.
Exploratory Grants in Cancer Control
PAR-21-341 (R21 - Clinical Trial Optional)
Expires October 9, 2024
Time-Sensitive Obesity Policy and Program Evaluation
PAR-21-305 (R01 - Clinical Trial Not Allowed)
Expires September 11, 2024
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility
PAR-22-083 (R01 Clinical Trial Not Allowed) and PAR-22-084 (R21 Clinical Trial Not Allowed)
Expires May 8, 2024
Notice of Special Interest: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-CA-22-037
Expires March 9, 2024
Modular R01s in Cancer Control and Population Sciences
PAR-21-190 (R01 - Clinical Trial Optional)
Expires March 8, 2024
Notice of Special Interest: Understanding the Effects of Cancer and Cancer Treatment on Aging Trajectories and Aging Outcomes
NOT-CA-21-031
Expires January 8, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3 - Clinical Trial Not Allowed) and PAR-20-314 (UH3 - Clinical Trials Not Allowed)
Expires October 11, 2023
Notice of Special Interest: Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults
NOT-CA-21-108
Expires May 08, 2023
Co-infection and Cancer
PAR-20-061 (R21 - Clinical Trial Not Allowed) and PAR-20-062 (R01 - Clinical Trial Not Allowed)
Expires January 8, 2023
Notice of Special Interest: Research in the Emergency Setting
NOT-NS-20-005
Expires September 8, 2022
Notice of Special Interest: Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
NOT-CA-22-056
Pre-Application webinar for NOT-CA-22-056
Expires May 27, 2022
Featured Resource
New Examples of Successfully Funded Cancer Epidemiology Grant Applications
The Sample Cancer Epidemiology Grant Applications webpage features new model R01, R03, R21, and R37 applications for researchers to reference when seeking funding for their own projects.
Meet Our Associate Director
An Interview with Kathy J. Helzlsouer, M.D., M.H.S.
Dr. Helzlsouer speaks about her background in oncology and epidemiology, the people and experiences that drive her passion for cancer research, and her ideas about future directions for EGRP.
What's New
Connect With Us
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730